Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders

…, A Lerner, R Ellajosyula, F Pasquier, D Galimberti… - Brain, 2020 - academic.oup.com
The behavioural variant of frontotemporal dementia (bvFTD) is a frequent cause of early-onset
dementia. The diagnosis of bvFTD remains challenging because of the limited accuracy …

[HTML][HTML] Role of oxidative damage in alzheimer's disease and neurodegeneration: From pathogenic mechanisms to biomarker discovery

…, M D'Anca, C Fenoglio, E Scarpini, D Galimberti - Antioxidants, 2021 - mdpi.com
Alzheimer’s disease (AD) is a neurodegenerative disorder accounting for over 50% of all
dementia patients and representing a leading cause of death worldwide for the global ageing …

EFNS‐ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease

…, C Cordonnier, T Fladby, D Galimberti… - European Journal of …, 2015 - Wiley Online Library
Background and purpose Previous studies have indicated clinical benefits of a combination
of cholinesterase inhibitors (Ch EI ) and memantine over Ch EI monotherapy in Alzheimer's …

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

…, P Bosco, R Clarke, C Brayne, D Galimberti… - Nature …, 2013 - nature.com
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …

[HTML][HTML] New insights into the genetic etiology of Alzheimer's disease and related dementias

…, L Froelich, B Fulton-Howard, D Galimberti… - Nature …, 2022 - nature.com
Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

…, G Annoni, D Seripa, D Galimberti, D Hannequin… - Nature …, 2009 - nature.com
The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed
susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we conducted a …

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

…, T Aspelund, LB Cantwell, F Garzia, D Galimberti… - Nature …, 2019 - nature.com
Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

…, A Franke, C Freeman, IY Frohlich, D Galimberti… - Nature …, 2013 - nature.com
… and D′ values equal to 1. If a perfectly tagging SNP was not available, we selected a SNP
that had equivalent MAF and the highest possible r 2 and D′ values. Estimation of r 2 and D

APOE and Alzheimer disease: a major gene with semi-dominant inheritance

…, P Piccardi, G Annoni, D Seripa, D Galimberti… - Molecular …, 2011 - nature.com
… Where P i,s (D)=I i,s is the incidence rate for individuals of sex s in age group i,, P i (G=g∣D)
is the prevalence of genotype g among those who develop the disease in age category i (…

[HTML][HTML] Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study …

…, M Grisoli, B Borroni, A Padovani, D Galimberti… - The Lancet …, 2015 - thelancet.com
Background Frontotemporal dementia is a highly heritable neurodegenerative disorder. In
about a third of patients, the disease is caused by autosomal dominant genetic mutations …